GLP-1-based treatments are designed to restore these helpful effects and improve overall glycaemic treatment and blood glucose control 1
Acetyl L-Carnitine (ALC) is a highly bioavailable form of L-carnitine that crosses the blood-brain barrier to support cognitive function, neurological health, mood balance, and energy production.* ALC promotes mitochondrial function, neurotransmitter synthesis, and antioxidant activity, making it a valuable tool for supporting brain health, nerve comfort, and overall metabolic vitality.* The acetyl derivative of L-carnitine, acetyl-L-carnitine is involved in the metabolism of protein, carbohydrates and fats, as well as the conversion of fats into energy.* Carnitine shuttles fats (triglycerides) into the mitochondria so these fats can be used for fuel.* Acetyl-L-carnitine crosses the blood brain barrier more readily than L-carnitine

July 2024: A matched cohort study of over 16,000 patients published in JAMA Ophthalmology found that patients taking glucagon-like peptide 1 receptor agonist (GLP-1 RA) may be at an increased risk of developing a devastating eye condition known as Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Optimization of protein c-myc-GST-human IL-8 detection in acetylated chitosan microplates Anti c-myc-ChBD antibody concentration, incubation time (1, 2, 4, 8 and 16 h) and the binding buffer for the binding reaction chitin- chitin binding domain were established